Learn more about lung cancer at www.YouAndLungC...
Chris discusses his treatment journey and experiences for his KRAS-positive lung cancer. Having the KRAS G12C lung cancer mutation has qualified him to have the targeted therapy adagrasib for his specific mutation. The treatments have slowed down the growth of Chris' lung cancer, allowing him to have a better quality of life with minimal side effects.
Негізгі бет Chris - What has your treatment experience been for your KRAS-positive lung cancer?
Пікірлер